Oncorus
Latest round
- Series B
Last raised
- Aug 2019
Total raised
- $48M
Investors
- 16
About Oncorus
Founded in 2015 and based in Massachusetts, US, Oncorus, Inc. is a biotechnology company that develops an immunotherapy platform focusing on the development of oncolytic virus therapies to aid the treatment of cancerous tumors. The company's platforms include Herpes Simplex Virus (HSV) and Synthetic Virus Platform.
Who invested in Oncorus
16 investors across 3 rounds
See all investors in Oncorus
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Oncorus
Who invested in Oncorus?
Oncorus has 16 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oncorus raised?
Oncorus has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Oncorus last raise money?
Oncorus's most recent round on record is a Series B, in Aug 2019.
What does Oncorus do?
Founded in 2015 and based in Massachusetts, US, Oncorus, Inc.
Where is Oncorus headquartered?
Oncorus is headquartered in Andover, US.
Which VCs invest in companies like Oncorus?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Oncorus's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Oncorus? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.